Bristol-Myers turns to AI startup to accelerate cancer research - STAT

Bristol-Myers turns to AI startup to accelerate cancer research  STATBristol-Myers/Celgene Deal Is About to Face a Crucial Test  Barron'sBristol-Myers Squibb taps Concerto HealthAI for real-world cancer data work and trial design  FierceBiotechBristol-Myers Squibb and Concerto HealthAI Sign Cancer Real World Data Agreement  BioSpaceView full coverage on Google News